Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Arvilet 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Arvincare Pharma

Salt Composition

Letrozole (2.5mg)

Overview Arvilet 2.5mg Tablet

Post-menopausal women with breast cancer may find relief with Arvilet 2.5mg tablets. This medication can be a standalone treatment or complement other therapies like surgery or radiation. In advanced breast cancer, it helps impede metastasis. Arvilet 2.5mg can be ingested with or without food, always adhering to your physician's prescribed dosage and duration for optimal results. Dosage adjustments depend on the specific treatment goal, determined by your doctor to manage your symptoms effectively. Continue using this medication as directed. Common side effects include hot flushes, tiredness, excessive perspiration, and elevated cholesterol (hypercholesterolemia). Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. A comprehensive list of all current medications is essential as interactions can affect Arvilet's efficacy. Disclose pregnancy or breastfeeding to your doctor. Pre-treatment and ongoing blood tests to monitor vitamin D levels and bone density may be conducted.

Uses of Arvilet 2.5mg Tablet

Managing breast cancer

Major Benefits of Arvilet 2.5mg Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Arvilet 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Arvilet 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Arvilet 2.5mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Arvilet 2.5mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.

How Arvilet 2.5mg Tablet works:

Arvilet 2.5mg tablets function as an aromatase inhibitor, reducing the body's estrogen production. This lower estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Arvilet 2.5mg Tablet consumption alongside alcohol poses no known adverse reactions.

PregnancyPregnancyUNSAFE

Use of Arvilet 2.5mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in animal and human studies reveals substantial adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Arvilet 2.5mg tablets due to potential infant toxicity.

DrivingDrivingUNSAFE

Taking a 2.5mg Arvilet tablet may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

The 2.5mg Arvilet tablet can be used safely by individuals with kidney disease; no dosage modification is needed. Nevertheless, data on its use in patients with end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Arvilet 2.5mg Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Arvilet 2.5mg Tablet :

Should you forget to take your Arvilet 2.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Arvilet 2.5mg Tablet

LabelValue
Type of Compound Benzhydryl compound
Potential for Dependence None.
Medication Classification Cancer treatments

FAQs on Arvilet 2.5mg Tablet

Aromatase inhibitor Arvilet, in its 2.5mg tablet formulation, is typically indicated for the management of breast cancer in postmenopausal women, including those whose menstruation has ceased following surgery or chemotherapy.
The medication Arvilet 2.5mg Tablet functions as an anti-estrogen agent. Its mechanism involves suppressing estrogen synthesis by inhibiting the aromatase enzyme, crucial for estrogen production. Estrogen fuels the growth of specific breast cancers, termed "estrogen-dependent cancers." Decreasing estrogen levels can therefore hinder tumor development.
For advanced breast cancer or cancer that has metastasized, continued Arvilet 2.5mg Tablet use is advised until disease progression is observed. Following tamoxifen therapy or surgery, Arvilet 2.5mg Tablet administration should last five years or until recurrence, whichever occurs sooner. Alternatively, a sequential regimen of two years of Arvilet 2.5mg Tablet followed by three years of tamoxifen may be employed.
Concurrent use of irbesartan and Arvilet 2.5mg tablets is permissible. Close monitoring of blood pressure is advised, as Arvilet 2.5mg tablets can elevate blood pressure. Seek medical attention if blood pressure management becomes challenging.
While rare, Arvilet 2.5mg Tablet use may be associated with cataract development. Therefore, prompt medical attention is advised if you develop blurred vision or eye discomfort.
Experiencing hot flashes may indicate a common side effect of Arvilet 2.5mg Tablet. This is often attributed to reduced estrogen. While these episodes usually lessen as your body acclimates to the medication, some individuals may continue to experience them throughout and for a short period after treatment. If this symptom proves significantly disruptive, seek advice from your physician for management options.
Arvilet 2.5mg Tablet's severe adverse reactions, though uncommon, include stroke, angina pectoris, myocardial infarction, thromboembolic events, cataracts, osteoporosis, and serious dermatological manifestations.
Treatment with Arvilet 2.5mg Tablets can lead to bone thinning or loss (osteoporosis) resulting from reduced estrogen levels. To monitor for osteoporosis, your physician may assess your bone mineral density before, throughout, and following your treatment.
The Ministry of Health and Family Welfare designates Arvilet 2.5mg Tablets solely for ovulation induction in women with anovulatory infertility.
Arvilet 2.5mg Tablet
224
MRP 260
13% off